Profile

Karyn E. Yonekawa, MD

Karyn E. Yonekawa, MD

Nephrology

On staff since July 2006

Academic Title: Clinical Associate Professor

    • Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ
      Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
      17762530 Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , 2007 Sept. : 547-53
    • Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ
      Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
      17287624 Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , 2007 Mar. : 97-103
    • Young G, Yonekawa KE, Nakagawa P, Nugent DJ
      Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits.
      15506032 Perfusion , 2004 : 283-8

Overview

Board Certification(s)

Pediatric Nephrology

Medical/Professional School

University of Pittsburgh School of Medicine, Pittsburgh

Residency

Pediatrics, Children's Hospital of Orange County, Orange

Fellowship

Pediatric Hematology-Oncology, Children's Hospital of Orange County, Orange
Pediatric Nephrology, University of Washington, Seattle

Clinical Interests

general pediatric nephrology